- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Carbon nanotubes inject antimycotics into cells and increase their effectiveness
Putting pharmaceutical agents into the body isn’t hard, but getting them into targeted areas can be problematic. If drugs aren’t taken up by a large enough proportion of cells, a suitable “transport agent” must be used. A French and Italian research team has successfully used carbon nanotubes as transport agents for antimycotics (antifungal agents). In addition, they have developed a strategy for attaching a second agent or marker to the nanotubes in a controlled fashion.
Carbon nanotubes are long, narrow nanoscale tubes made of multiple layers of carbon atoms arranged in graphite-like sheets. “They can drill through cell membranes like tiny needles,” explains Alberto Bianco, “without damaging the cell.” If proteins or nucleic acids are attached to the nanotubes, they come right along through the membrane. Bianco and a team of scientists from CNRS (Centre National de la Recherche Scientifique of Strasbourg and the University of Trieste wanted to determine if this concept could also be extended to small pharmaceutical molecules such as antibiotics or cancer drugs. They were particularly intrigued by the idea of attaching not one, but two different “passengers.” This would make it possible to carry out combination therapies with two different drugs or to trace the uptake of a drug by using a marker.
Attaching two different molecules to a carbon nanotube in a targeted, controlled, and fully independent manner requires a clever strategy. The researchers thus put two different types of anchor sites, equipped with protective “caps,” on the tips and sides walls of the tubes. They removed the first type of “cap” and attached one kind of molecule, then removed the second type of cap and attached another type of molecule. The researchers thus loaded the nanotubes with the antimycotic amphotericin B, as well as a fluorescence dye.
When coupled to the nanotubes, the drug loses the toxic side effects typical of treatment with amphotericin B. At the same time, its effectiveness against fungi is improved. One reason for this could be the improved solubility in water; in addition, the amphotericin is prevented from forming clumps. “Our approach could help amphotericin B become more widely used against chronic fungal infections,” hopes Bianco.
A particularly attractive target is carbon nanotubes equipped with both a drug and a “guide.” The guide could then recognize certain types of cells, such as tumor cells, and could conduct the transporter to these cells to deliver the drug preferentially to where it is needed.
Author: Alberto Bianco, Institut de Biologie Moléculaire et Cellulaire, Strasbourg (France), link.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Healthcare Nanotechnology (Nanomedicine) Market Size To 2020 June 5th, 2015
Cellulose from wood can be printed in 3-D June 17th, 2015
Chivalrous Knight Does Pro Bono June 27th, 2015